Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Atazanavir sulphate |
Is a |
False |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing atazanavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir (as atazanavir sulfate) 100 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atazanavir (as atazanavir sulfate) 150 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atazanavir (as atazanavir sulfate) 200 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atazanavir-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir- and cobicistat-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir- and cobicistat-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir (as atazanavir sulfate) 100 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir (as atazanavir sulfate) 150 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir (as atazanavir sulfate) 200 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir sulphate |
Is modification of (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atazanavir and cobicistat only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atazanavir and cobicistat only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atazanavir (as atazanavir sulfate) 300 milligram and ritonavir 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only atazanavir and ritonavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing atazanavir and ritonavir in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atazanavir and ritonavir only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing atazanavir and ritonavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Atazanavir (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |